{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:31:54Z","timestamp":1791599514497,"version":"4.3.4"},"reference-count":40,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0561","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T22:10:00Z","timestamp":1676326200000},"page":"519-528","source":"Crossref","is-referenced-by-count":5,"title":["A questionnaire-based survey of medical conditions in adults with Prader-Willi syndrome in Japan: implications for transitional care"],"prefix":"10.1507","volume":"70","author":[{"given":"Masanobu","family":"Kawai","sequence":"first","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Department of Gastroenterology, Nutrition, and Endocrinology, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"},{"name":"Department of Bone and Mineral Research, Research Institute, Osaka Women\u2019s and Children\u2019s Hospital, Izumi 594-1101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Muroya","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Department of Pediatrics, Dokkyo Medical University Saitama Medical Center, Koshigaya 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ihara","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Department of Psychiatry, Dokkyo Medical University Saitama Medical Center, Koshigaya 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Department of Diabetes and Endocrinology, Nara Medical University, Kashihara 634-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Research Committee on Clinical Management of Prader-Willi syndrome, Research on Measures for Intractable Diseases, Health and Labour Sciences Research Grants, Tokyo, Japan"},{"name":"Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"},{"name":"Department of Pediatrics, Hamamatsu Medical Center, Hamamatsu 431-3192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14: 10\u201326.","DOI":"10.1038\/gim.0b013e31822bead0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38: 1249\u20131263.","DOI":"10.1007\/s40618-015-0312-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tauber M, Hoybye C (2021) Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol 9: 235\u2013246.","DOI":"10.1016\/S2213-8587(21)00002-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nagai T, Obata K, Tonoki H, Temma S, Murakami N, et al. (2005) Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 136: 45\u201348.","DOI":"10.1002\/ajmg.a.30777"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, et al. (2001) Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 38: 792\u2013798.","DOI":"10.1136\/jmg.38.11.792"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Butler MG, Manzardo AM, Heinemann J, Loker C, Loker J (2017) Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey. Genet Med 19: 635\u2013642.","DOI":"10.1038\/gim.2016.178"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Schmidt H, Schwarz HP, Enders A (2001) Dietary intervention in the first four years prevents abnormal weight gain but negatively affects height development in Prader-Willi syndrome. Acta Paediatr 90: 468\u2013469.","DOI":"10.1111\/j.1651-2227.2001.tb00456.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Schmidt H, Pozza SB, Bonfig W, Schwarz HP, Dokoupil K (2008) Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up. J Pediatr Endocrinol Metab 21: 651\u2013655.","DOI":"10.1515\/JPEM.2008.21.7.651"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, et al. (2013) GrowthHormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98: E1072\u2013E1087.","DOI":"10.1210\/jc.2012-3888"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Passone CGB, Franco RR, Ito SS, Trindade E, Polak M, et al. (2020) Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open 4: e000630.","DOI":"10.1136\/bmjpo-2019-000630"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sanchez-Ortiga R, Klibanski A, Tritos NA (2012) Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf) 77: 86\u201393.","DOI":"10.1111\/j.1365-2265.2011.04303.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Pellikaan K, Rosenberg AGW, Davidse K, Kattentidt-Mouravieva AA, Kersseboom R, et al. (2021) Effects of childhood multidisciplinary care and growth hormone treatment on health problems in adults with Prader-Willi syndrome. J Clin Med 10: 3250.","DOI":"10.3390\/jcm10153250"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Salvatoni A, Nosetti L, Salvatore S, Agosti M (2021) Benefits of multidisciplinary care in Prader-Willi syndrome. Expert Rev Endocrinol Metab 16: 63\u201371.","DOI":"10.1080\/17446651.2021.1898375"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Duis J, van Wattum PJ, Scheimann A, Salehi P, Brokamp E, et al. (2019) A multidisciplinary approach to the clinical management of Prader-Willi syndrome. Mol Genet Genomic Med 7: e514.","DOI":"10.1002\/mgg3.514"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Paepegaey AC, Coupaye M, Jaziri A, Menesguen F, Dubern B, et al. (2018) Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome. Endocr Connect 7: 663\u2013672.","DOI":"10.1530\/EC-18-0089"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine (2002) A consensus statement on health care transitions for young adults with special health care needs. Pediatrics 110: 1304\u20131306.","DOI":"10.1542\/peds.110.S3.1304"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Pedersen M, Hoybye C (2021) An adapted model for transition to adult care in young adults with Prader-Willi syndrome. J Clin Med 10: 1991.","DOI":"10.3390\/jcm10091991"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Rosenberg AGW, Wellink CM, Tellez Garcia JM, Pellikaan K, Van Abswoude DH, et al. (2022) Health problems in adults with Prader-Willi syndrome of different genetic subtypes: cohort study, meta-analysis and review of the literature. J Clin Med 11: 4033.","DOI":"10.3390\/jcm11144033"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Pellikaan K, Rosenberg AGW, Kattentidt-Mouravieva AA, Kersseboom R, Bos-Roubos AG, et al. (2020) Missed diagnoses and health problems in adults with Prader-Willi syndrome: recommendations for screening and treatment. J Clin Endocrinol Metab 105: e4671\u2013e4687.","DOI":"10.1210\/clinem\/dgaa621"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 van Abswoude DH, Pellikaan K, Rosenberg AGW, Davidse K, Coupaye M, et al. (2022) Bone health in adults with Prader-Willi syndrome: clinical recommendations based on a multicenter cohort study. J Clin Endocrinol Metab 108: 59\u201384.","DOI":"10.1210\/clinem\/dgac556"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, et al. (2010) Endocrine disorders in children with Prader-Willi syndrome\u2014data from 142 children of the French database. Horm Res Paediatr 74: 121\u2013128.","DOI":"10.1159\/000313377"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, et al. (2002) Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 44: 248\u2013255.","DOI":"10.1017\/S001216220100202X"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Fintini D, Grugni G, Bocchini S, Brufani C, Di Candia S, et al. (2016) Disorders of glucose metabolism in Prader-Willi syndrome: results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis 26: 842\u2013847.","DOI":"10.1016\/j.numecd.2016.05.010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Pacoricona Alfaro DL, Lemoine P, Ehlinger V, Molinas C, Diene G, et al. (2019) Causes of death in Prader-Willi syndrome: lessons from 11 years\u2019 experience of a national reference center. Orphanet J Rare Dis 14: 238.","DOI":"10.1186\/s13023-019-1214-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Proffitt J, Osann K, McManus B, Kimonis VE, Heinemann J, et al. (2019) Contributing factors of mortality in Prader-Willi syndrome. Am J Med Genet A 179: 196\u2013205.","DOI":"10.1002\/ajmg.a.60688"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Manzardo AM, Loker J, Heinemann J, Loker C, Butler MG (2018) Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey. Genet Med 20: 24\u201330.","DOI":"10.1038\/gim.2017.92"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity (2002) New criteria for \u2018obesity disease\u2019 in Japan. Circ J 66: 987\u2013992.","DOI":"10.1253\/circj.66.987"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Laurier V, Lapeyrade A, Copet P, Demeer G, Silvie M, et al. (2015) Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res 59: 411\u2013421.","DOI":"10.1111\/jir.12140"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, van Nieuwpoort IC, Drent ML, et al. (2011) Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A 155A: 2112\u20132124.","DOI":"10.1002\/ajmg.a.34171"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Oto Y, Murakami N, Inoue T, Matsubara K, Saima S, et al. (2021) Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study. J Pediatr Endocrinol Metab 35: 89\u201396.","DOI":"10.1515\/jpem-2021-0555"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Irizarry KA, Miller M, Freemark M, Haqq AM (2016) Prader Willi syndrome: genetics, metabolomics, hormonal function, and new approaches to therapy. Adv Pediatr 63: 47\u201377.","DOI":"10.1016\/j.yapd.2016.04.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Sun C, Kovacs P, Guiu-Jurado E (2020) Genetics of obesity in East Asians. Front Genet 11: 575049.","DOI":"10.3389\/fgene.2020.575049"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Koizumi M, Ida S, Shoji Y, Nishimoto Y, Etani Y, et al. (2018) Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome. Endocr J 65: 1127\u20131137.","DOI":"10.1507\/endocrj.EJ18-0107"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kuppens RJ, Bakker NE, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Donze SH, et al. (2016) Beneficial effects of GH in young adults with Prader-Willi syndrome: a 2-year crossover trial. J Clin Endocrinol Metab 101: 4110\u20134116.","DOI":"10.1210\/jc.2016-2594"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Oto Y, Tanaka Y, Abe Y, Obata K, Tsuchiya T, et al. (2014) Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome. Am J Med Genet A 164A: 671\u2013675.","DOI":"10.1002\/ajmg.a.36355"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Eiholzer U, l\u2019Allemand D, Rousson V, Schlumpf M, Gasser T, et al. (2006) Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart- Willi syndrome. J Clin Endocrinol Metab 91: 892\u2013898.","DOI":"10.1210\/jc.2005-0902"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC (2012) Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 97: E452\u2013E459.","DOI":"10.1210\/jc.2011-1954"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Siemensma EP, van Alfen-van der Velden AA, Otten BJ, Laven JS, Hokken-Koelega AC (2012) Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study. J Clin Endocrinol Metab 97: E1766\u2013E1773.","DOI":"10.1210\/jc.2012-1595"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Heksch R, Kamboj M, Anglin K, Obrynba K (2017) Review of Prader-Willi syndrome: the endocrine approach. Transl Pediatr 6: 274\u2013285.","DOI":"10.21037\/tp.2017.09.04"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Tanaka Y, Abe Y, Oto Y, Itabashi H, Shiraishi M, et al. (2013) Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet A 161A: 27\u201333.","DOI":"10.1002\/ajmg.a.35653"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0561\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:45:22Z","timestamp":1715316322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0561\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0561","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0561"}}